AlainKaticMD

Psychiatry • Bellaire, TX

Child & Adolescent Psychiatry

Physician

Join to view full profile

Dr. Katic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Katic's full profile

Already have an account?

Office
6330 West Loop S
Ste 650
Bellaire, TX 77401
Phone+1 713-527-8448

Fax+1 713-527-7880

Education & Training

Boston Children’s HospitalFellowship, Child and Adolescent Psychiatry, 1994 - 1996
Butler Hospital/Brown UniversityResidency, Psychiatry, 1991 - 1994
University of Texas Medical Branch School of MedicineClass of 1991

Certifications & Licensure

CA State Medical License 1996 - Present
TX State Medical License 2000 - 2025
MA State Medical License 1992 - 2003

Clinical Trials

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01
Completed
Phase 2
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder Start of enrollment: 2015 Aug 21
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

10 citations
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder
Rakesh K. Jain, Alain Katic
The Primary Care Companion for CNS Disorders. 2016-08-18
21 citations
A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System in Depressed Adolescents
Melissa P. DelBello, Thomas J. Hochadel, Kimberly Blanchard Portland, Albert J. Azzaro, Alain Katic
Journal of Child and Adolescent Psychopharmacology. 2014-08-01
5 citations
Treatment outcomes with lisdexamfetamine dimesylate in children who have attention-deficit/hyperactivity disorder with emotional control impairments.
Alain Katic, Bryan Dirks, Thomas Babcock, Brian Scheckner, Ben Adeyi
Journal of Child and Adolescent Psychopharmacology. 2013-08-16